This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by KIRKING, D. M. Search for Related Content Social Bookmarking                         What's this?

New Horizons in Pharmaceutical Technology

The benefits they provide have contributed toward making drugs the most commonly used treatment modality. Although drugs account for less than 10 percent of all health care expenditures, their total costs can be substantial when one considers the impact of adverse effects as well as the problems resulting from misprescribing and misuse. The 1980s will see the introduction of a large number and variety of new drugs and new ways of delivering drugs to the body. The goals of these developments include increased effectiveness, decreased seriousness and frequency of adverse effects, and less complicated dosing regimes. This new technology raises questions regarding the optimal prescribing, distribution, financing, and use of these new drugs. It is also important to consider what actions should be taken to assure that continued growth in drug technology will occur and that this growth be directed toward the development of drugs that offer significant advantages over existing therapies. Rational policy must consider not only the costs of drugs themselves but also the potential for drugs to reduce the overall cost of health care.

The ANNALS of the American Academy of Political and Social Science, Vol. 468, No. 1, 182-195 (1983)
DOI: 10.1177/0002716283468001012


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?